Family Gives Up Disputed Patent, Ending Trial With Boies' Client

, The Recorder


But former McDermott partner muddied by allegations says he will bring his own suit.

This content has been archived. It is available exclusively through our partner LexisNexis®.

To view this content, please continue to Lexis Advance®.

Continue to Lexis Advance®

Not a Lexis Advance® Subscriber? Subscribe Now

Why am I seeing this?

LexisNexis® is now the exclusive third party online distributor of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® customers will be able to access and use ALM's content by subscribing to the LexisNexis® services via Lexis Advance®. This includes content from the National Law Journal®, The American Lawyer®, Law Technology News®, The New York Law Journal® and Corporate Counsel®, as well as ALM's other newspapers, directories, legal treatises, published and unpublished court opinions, and other sources of legal information.

ALM's content plays a significant role in your work and research, and now through this alliance LexisNexis® will bring you access to an even more comprehensive collection of legal content.

For questions call 1-877-256-2472 or contact us at

What's being said

  • not available

    In response to the comments of Theranos‘ counsel, Fuisz Pharma, LLC, Dr. Richard Fuisz and Joseph Fuisz deny that the case was settled based upon the testimony presented, and state that the matter was settled to permit the both parties‘ businesses to move forward in a positive direction. Theranos and the Fuisz defendants have agreed to the following joint statement regarding the resolution of their case:

    Theranos Inc. and Fuisz Pharma LLC, and their respective principals, have resolved their pending lawsuit. The parties have stipulated to a judgment that the patent at issue is invalid. Each party will bear its own costs, and no party has made a payment to the other. The parties look forward to moving on without the burden of this litigation.

  • not available

    Win = invalidating a patent with non-party prior art and at the same time claiming the invalidated patent was the same as Boies‘ client‘s patent? Huh?

    As for "truth", let me share some emails on the work for release program -

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article #1202647306319

Thank you!

This article's comments will be reviewed.